|
|
EQSAdhoc: BB BIOTECH AG / Key words: Interim Report
BB Biotech AG publishes its interim report
26Apr2024 / 07:00 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation EU No 596/2014, transmitted by EQS News a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.... Lire le communiqué |
|
| |
|
| |
|
|
EQSNews: BB BIOTECH AG
/ Key words: Interim Report
BB Biotech presents solid firstquarter results; biotech stock market impacted by shifting views on interest rates
26.04.2024 / 07:00 CET/CEST
The issuer is solely responsible for the content of this announcement.
Media release as at April 26, 2024... Lire le communiqué |
|
| |
|
| |
|
|
EQSNews: BB BIOTECH AG
/ Key words: AGM/EGM/Dividend
Shareholders at BB Biotech AG’s AGM vote in favor of all proposals and approve the dividend of CHF 2.00 per share
21.03.2024 / 18:00 CET/CEST
The issuer is solely responsible for the content of this announcement.
Media release of March 21, 20... Lire le communiqué |
|
| |
|
| |
|
|
EQSAdhoc: BB BIOTECH AG / Key words: Annual Report/Dividend
BB Biotech AG publishes its 2023 annual report
16Feb2024 / 07:00 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation EU No 596/2014, transmitted by EQS News a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.... Lire le communiqué |
|
| |
|
| |
|
|
EQSNews: BB BIOTECH AG
/ Key words: Dividend
Investor interest returns – dividend yield remains high for 2024
14.02.2024 / 07:00 CET/CEST
The issuer is solely responsible for the content of this announcement.
Release as at February 14, 2024Investor interest... Lire le communiqué |
|
| |
|
| |
|
|
EQSAdhoc: BB BIOTECH AG / Key words: Annual Results/Personnel
BB Biotech AG publishes financial results for 2023 and changes to the Board of Directors
19Jan2024 / 07:00 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation EU No 596/2014, transmitted by EQS News a service of EQS Group AG.
The issuer is solely responsible for... Lire le communiqué |
|
| |
|
| |
|
|
EQSNews: BB BIOTECH AG
/ Key words: Annual Results/Dividend
BB Biotech AG: End of year biotech equity market rally – M&A and end of rate hike cycle
19.01.2024 / 07:00 CET/CEST
The issuer is solely responsible for the content of this announcement.
Media release as at January 19, 2024... Lire le communiqué |
|
| |
|
| |
